home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Pier Shareware 6
/
The_Pier_Shareware_Number_6_(The_Pier_Exchange)_(1995).iso
/
026
/
med9410a.zip
/
M94A0132.TXT
< prev
next >
Wrap
Text File
|
1994-10-01
|
3KB
|
42 lines
Document 0132
DOCN M94A0132
TI Risk factors for HIV-1 seroprevalence among drug injectors in the
cocaine-using environment of Rio de Janeiro.
DT 9412
AU Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des
Jarlais DC; Nucleo de Estudos e Pesquisas em Atencao ao Uso de Drogas;
(NEPAD), Rio de Janeiro, Brazil.
SO Addiction. 1994 Jun;89(6):689-98. Unique Identifier : AIDSLINE
MED/94348362
AB To determine risk factors for HIV-1 among drug injectors in Rio de
Janeiro, where cocaine is the dominant drug of injection, subjects were
recruited using the criteria and interview instrument of the World
Health Organization's Cross-National Study of HIV infection and risk
behaviour in injecting drug users. HIV antibody test results were
derived both from serum tests and from self-reports of previous tests
(documented evidence of self-reported seropositivity was required). The
analytical sample consists of 123 subjects, recruited both at drug abuse
treatment sites and at street locations. Of 27 subjects with both
serological and self-reported antibody status data, 20 reported previous
negative tests; of these three had positive sera and may have
seroconverted. Seven subjects reporting prior positive serostatus all
tested positive. For the 123 subjects, seroprevalence was 34%.
Independent significant risk factors in multivariate logistic regression
with backwards elimination are: years of injection greater than 5; being
a male who has had sex with men in the previous 5 years; and not having
taken deliberate steps to protect oneself against AIDS. These findings
indicate that homosexual/bisexual male drug injectors may be a bridge
group through which HIV is entering drug-injecting networks in Rio de
Janeiro. Efforts by drug injectors to reduce their risk of infection
seem to have protective effects. This underscores the importance of HIV
prevention efforts aimed at drug injectors.
DE Brazil/EPIDEMIOLOGY *Cocaine Comorbidity HIV
Seropositivity/COMPLICATIONS/DIAGNOSIS/*EPIDEMIOLOGY *HIV-1 Risk
Factors Self Assessment (Psychology) Substance Abuse,
Intravenous/*COMPLICATIONS Support, Non-U.S. Gov't Support, U.S.
Gov't, P.H.S. JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).